Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Novato, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BIOMARIN PHARMACEUTICAL INC has filed 2,724 SEC EDGAR filings since 04 May 1999

SEC filing history

Showing 926-950 of 1,000 matching filings.

Per page
25
Current page
38
4

FORM 4

Filing date
04 May 2017
Reporting date
02 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-26727

FORM 10-Q Q1 2017

Filing date
04 May 2017
Reporting date
31 Mar 2017
Next action
Verify source filing
8-K File 000-26727

FORM 8-K

Filing date
04 May 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 May 2017
Reporting date
27 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
28 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Apr 2017
Reporting date
25 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-26727

DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

Filing date
25 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-26727

DEFINITIVE PROXY STATEMENT

Filing date
25 Apr 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26727

FORM 8-K

Filing date
13 Apr 2017
Reporting date
12 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-26727

PRELIMINARY PROXY STATEMENT

Filing date
11 Apr 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Apr 2017
Reporting date
04 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-26727

CT ORDER filing

Filing date
06 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-77701

CT ORDER filing

Filing date
05 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Mar 2017
Reporting date
29 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2017
Reporting date
15 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2017
Reporting date
15 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2017
Reporting date
15 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .